4
Changes in Ownership
Mereo BioPharma Group plc Filed Acc 0000950170-25-009787
Options or other derivatives
- Chief Executive Officer acquired 825,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Scots-Knight Denise · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-25 | Grant or award : show line 1 in the form Share Options (Right to buy) | +825,000 | 825,000 | D |
Loading xslF345X05/ownership.xml…